RYANODEX dantrolene sodium
NDC 42367-540, dantrolene sodium, injection, suspension, from Eagle Pharmaceuticals, Inc..
- Product NDC
- 42367-540
- Status
- Listed
- Labeler
- Eagle Pharmaceuticals, Inc.
- Dosage form
- INJECTION, SUSPENSION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA205579
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/42367-540 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DANTROLENE SODIUM250 mg/5mL
Pharmacologic classes
Decreased Striated Muscle Contraction [PE]; Decreased Striated Muscle Tone [PE]; Skeletal Muscle Relaxant [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 42367-540-32 | 42367054032 | 1 VIAL in 1 CARTON (42367-540-32) / 20 mL in 1 VIAL |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/8f7b3ac0-604d-4c78-b545-5e0f8ea3d698
Use it
Look up 42367-540 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/42367-540 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 42367-540. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.